↓ Skip to main content

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
Published in
Journal of Experimental & Clinical Cancer Research, February 2022
DOI 10.1186/s13046-022-02243-2
Pubmed ID
Authors

Yanyan Zhang, Shuyi Zhu, Yuanyuan Du, Fan Xu, Wenbo Sun, Zhi Xu, Xiumei Wang, Peipei Qian, Qin Zhang, Jifeng Feng, Yong Xu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 31%
Student > Postgraduate 2 15%
Student > Ph. D. Student 1 8%
Researcher 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 4 31%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 23%
Biochemistry, Genetics and Molecular Biology 2 15%
Environmental Science 1 8%
Immunology and Microbiology 1 8%
Chemistry 1 8%
Other 0 0%
Unknown 5 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2022.
All research outputs
#15,754,982
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#930
of 2,383 outputs
Outputs of similar age
#226,321
of 448,973 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#55
of 104 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,973 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.